Consistent with the rM-ed neutrophil findings, flow cytometry showed that 4-OI treatment significantly normalized the activated neutrophil phenotype in the peripheral blood of colitis mice, as shown by reduced CD11b expression and increased CD62L expression levels comparable to those in normal control neutrophils (Fig. 7k-l). This evidence concerns the gene SELL and colitis.